chr12-43375460-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_025003.5(ADAMTS20):āc.5365G>Cā(p.Glu1789Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,613,208 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_025003.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADAMTS20 | NM_025003.5 | c.5365G>C | p.Glu1789Gln | missense_variant | 36/39 | ENST00000389420.8 | |
ADAMTS20 | XM_011538754.3 | c.5368G>C | p.Glu1790Gln | missense_variant | 36/39 | ||
ADAMTS20 | XM_017019979.2 | c.4153G>C | p.Glu1385Gln | missense_variant | 29/32 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADAMTS20 | ENST00000389420.8 | c.5365G>C | p.Glu1789Gln | missense_variant | 36/39 | 1 | NM_025003.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251088Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135704
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461040Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 726850
GnomAD4 genome AF: 0.000138 AC: 21AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2024 | The c.5365G>C (p.E1789Q) alteration is located in exon 36 (coding exon 36) of the ADAMTS20 gene. This alteration results from a G to C substitution at nucleotide position 5365, causing the glutamic acid (E) at amino acid position 1789 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at